Curcumin-qingdai (CURQD) in combination with vedolizumab versus vedolizumab alone as induction and maintenance therapy in ulcerative colitis

Active Project Grant Awarded Last action

Award ID
HT94252510942
Recipient
Awarding agency
Obligated
$12,173,913

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 24% complete
Originally
Place of performance
New York, NY 10029, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $11,362,700
Amendment $0
Original award $811,213

Subawards

Subrecipient Amount Awarded
The Sheba Fund For Health Services And Research (R.a.) Planning Year: Prepare and initiate a PK trial - Conduct in vitro spiking experiment with exogenous added herbal compounds to develop LCMS/MS technique for… $59,423
The University Of Chicago Dr. David Rubin is contributing directly to study design, study recruitment and management at the University of Chicago, and importantly, contributing to the… $32,169

Quick answers

Who received award HT94252510942?

HT94252510942 was awarded to Icahn School Of Medicine At Mount Sinai by Defense Health Agency (Department of Defense) on September 1, 2025.

How much is award HT94252510942 worth?

$12,173,913 has been obligated on HT94252510942.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login